Saltar al contenido

Gilead Sciences, Inc. (GILD) stock: revenue, earnings & dividend

Gilead Sciences, Inc. (GILD, Nasdaq): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener GILD · Nasdaq Pharma & Biotech US-CA

Key figures

Fiscal year
2025
Revenue
29.4 bn $
Revenue growth
2.4 %
Revenue growth 5y (p.a.)
3.6 %
Net income
8.51 bn $
Net margin
28.9 %
Operating margin
34 %
Earnings per share (diluted)
6.78 $
Dividend per share
3.16 $
Payout ratio
46.6 %
Consecutive dividend years
11 years
Consecutive dividend raises
10 years
Dividend growth 5y (p.a.)
3 %
Total assets
59 bn $
Equity
22.7 bn $
Equity ratio
38.5 %
Return on equity
37.5 %
Cash
7.56 bn $
Operating cash flow
10 bn $
Free cash flow
9.46 bn $
Shares outstanding
1,240,338,614

History

Revenue by fiscal year

2016 30.4 bn $
2017 26.1 bn $
2018 22.1 bn $
2019 22.4 bn $
2020 24.7 bn $
2021 27.3 bn $
2022 27.3 bn $
2023 27.1 bn $
2024 28.8 bn $
2025 29.4 bn $

Net income by fiscal year

2016 13.5 bn $
2017 4.63 bn $
2018 5.46 bn $
2019 5.39 bn $
2020 123 m $
2021 6.23 bn $
2022 4.59 bn $
2023 5.67 bn $
2024 480 m $
2025 8.51 bn $

Dividend per share

2016 1.84 $
2017 2.08 $
2018 2.28 $
2019 2.52 $
2020 2.72 $
2021 2.84 $
2022 2.92 $
2023 3.00 $
2024 3.08 $
2025 3.16 $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
202529.4 bn $8.51 bn $6.78 $3.16 $10 bn $
202428.8 bn $480 m $0.38 $3.08 $10.8 bn $
202327.1 bn $5.67 bn $4.50 $3.00 $8.01 bn $
202227.3 bn $4.59 bn $3.64 $2.92 $9.07 bn $
202127.3 bn $6.23 bn $4.93 $2.84 $11.4 bn $
202024.7 bn $123 m $0.10 $2.72 $8.17 bn $
201922.4 bn $5.39 bn $4.22 $2.52 $9.14 bn $
201822.1 bn $5.46 bn $4.17 $2.28 $8.4 bn $
201726.1 bn $4.63 bn $3.51 $2.08 $11.9 bn $
201630.4 bn $13.5 bn $9.94 $1.84 $17 bn $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)